vCJD and transfusion risk

被引:0
|
作者
Stephenson, J
机构
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1313 / 1313
页数:1
相关论文
共 50 条
  • [31] Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient
    Peden, AH
    Head, MW
    Ritchie, DL
    Bell, JE
    Ironside, JW
    LANCET, 2004, 364 (9433): : 527 - 529
  • [32] REDUCING THE RISK OF VCJD TRANSMISSION: A SAFETY TRIAL OF PRION-FILTERED VERSUS STANDARD RED CELLS TRANSFUSION IN SURGICAL PATIENTS (PRISM)
    Elebute, M.
    Mora, A.
    Choo, L.
    MacRury, C.
    Llewelyn, C.
    Purohit, S.
    Hicks, V.
    Malfroy, M.
    Deary, A.
    Reed, T.
    Meredith, S.
    Manson, L.
    Williamson, L.
    HAEMATOLOGICA, 2012, 97 : 162 - 162
  • [33] vCJD tissue distribution and transmission by transfusion - a worst-case scenario coming true?
    Aguzzi, A
    Glatzel, M
    LANCET, 2004, 363 (9407): : 411 - 412
  • [34] No Major Change in vCJD Agent Strain after Secondary Transmission via Blood Transfusion
    Bishop, Matthew T.
    Ritchie, Diane L.
    Will, Robert G.
    Ironside, James W.
    Head, Mark W.
    Thomson, Val
    Bruce, Moira
    Manson, Jean C.
    PLOS ONE, 2008, 3 (08):
  • [35] The shifting sands of uncertainty: Risk construction and BSE/vCJD
    Kewell, Beth
    Beck, Matthias
    HEALTH RISK & SOCIETY, 2008, 10 (02) : 133 - 148
  • [37] Leukoreduction and blood-borne vCJD transmission risk
    Douet, Jean Yves
    Bujdoso, Raymond
    Andreoletti, Olivier
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (01) : 36 - 40
  • [38] vCJD
    不详
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2010, 8 (01) : 60 - 60
  • [39] Managing theoretical vCJD risk - Policy to reduce the risk costs the environment dear
    Hotchkiss, Julie
    BRITISH MEDICAL JOURNAL, 2008, 337 (7672):
  • [40] Healthy carriers could increase vCJD risk, scientists say
    Bonn, D
    LANCET, 2000, 356 (9232): : 833 - 833